The administration of Qishen Yiqi dropping pill did not demonstrate any significant impact on composite endpoint events (including all-cause mortality and HF re-hospitalization rate) or BNP levels, however, it exhibited potential for enhancing the quality of life of patients. Here, NPPB is linked to hydrops fetalis.